Tag: BetterLife Pharma - Page 4 - Psychedelic Alpha

Read more about the article Former FDA Psychiatry Division Director Dr. Thomas Laughren Joins BetterLife as Regulatory Advisor

Former FDA Psychiatry Division Director Dr. Thomas Laughren Joins BetterLife as Regulatory Advisor

Post published:April 8, 2021
Post category:Press Release

Read more about the article BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003

BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003

Post published:March 11, 2021
Post category:Press Release

Read more about the article BetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies

BetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies

Post published:March 8, 2021
Post category:Press Release

Read more about the article BetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A Manufacturing

BetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A Manufacturing

Post published:March 3, 2021
Post category:Press Release

Read more about the article BetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use Disorder

BetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use Disorder

Post published:February 2, 2021
Post category:Press Release

Read more about the article BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies

BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies

Post published:January 28, 2021
Post category:Press Release

Read more about the article BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada

BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada

Post published:January 19, 2021
Post category:Press Release

Read more about the article BetterLife Provides Shareholder Update and 2021 Product Development Roadmap

BetterLife Provides Shareholder Update and 2021 Product Development Roadmap

Post published:January 12, 2021
Post category:Press Release

Read more about the article BetterLife Announces Formation of Next Generation Psychedelic Research Advisory Board

BetterLife Announces Formation of Next Generation Psychedelic Research Advisory Board

Post published:January 7, 2021
Post category:Press Release

Read more about the article BetterLife Files Patent for the Treatment of MDD Utilizing its Second-Generation Psychedelic Derivative for 2-Bromo-LSD

BetterLife Files Patent for the Treatment of MDD Utilizing its Second-Generation Psychedelic Derivative for 2-Bromo-LSD

Post published:January 4, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.